skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello team,

Ross Healy was on BNN and suggested that BAM is valued at the absolute top end of it’s range “the stock is at 2x book value which is at a high over the last 15 years”. Not done he then added “the 2022 earnings have gone right into the ditch and our FMV has cratered with it, it’s no wonder shares are softening.”

I follow Brookfield as closely as anyone and earnings going in a ditch? I see a beat on DE, FFO, increased flows from private funds. I see increased tailwinds from the spin off to the transition fund to the increased fee bearing capital and continued capital deployment. Also, I see the CURRENT NAV at $68 a share so a ~13% discount.

Needless to say I am on the polar opposite side of his commentary.

What am I missing hear and can you please elaborate on his argument.

Thank you.

Read Answer Asked by James on April 05, 2022
Q: The following was in the Globe today and I quote: "Canaccord Genuity’s Doug Taylor lowered his Well Health Technologies Corp. to $10 from $12 with a “buy” rating, while PI Financial’s Kris Thompson cut his target to $9 from $10.50 with a “buy” rating. The AVERAGE is $10.12."

And yet is sits at $5.10. After a good, solid quarter. I just shake my head and wonder what I am missing?

If it wasn't for 5i I would have all my money in a sock hidden under the mattress.
Read Answer Asked by Bryan on April 05, 2022
Q: Topicus has a press release revealing they are going to buy a tech firm that creates vertical market software for numerous markets in Poland. I’ve converted the $ to USD because I don’t understand the currency:

Offer price: $61 million
Annual revenue: $38 million
P/S multiple: 1.6X
Free cash flow per annum: $5.5 million

1) What do you think of the deal?
2) Did Constellation Software ever buy a public company? If so, when and what was the name or names?

Thanks for the great service.
Read Answer Asked by Michael on April 04, 2022
Q: My original 5% position @ $8.18 p/p is now reduced to 3%.Your initial recommendation is $2.83 with current rating of B+.The famous billionarie,Mr Kai Sing Li is part owner. Despite so many acquistions the stock has steadily declined from a 1yr H of $8.86 in July,2021 to recent low of $3.76 in mid Jan & appears to have found a base of some $4.Good Q on Mar 31 resulted in rise of.29(after high of + .56)& dropped 0.20 to $5.01 the next trading day.Very disappointed with the performance..Your thoughts. Txs for u usual great services & views
Read Answer Asked by Peter on April 04, 2022
Q: We'd all love to get a look at a few stock prices from 5 years in the future. Get a big winner, or avoid a big loser, with no risk. If you could get a list of the prices of 10 Canadian stocks 5 years from now, which ones would you pick? Let's say stocks with a min market cap of roughly $1 billion Cdn.
Read Answer Asked by Dan on April 01, 2022
Q: Hi 5i,
I read your market update with interest. You guys tend to be adders and trimmers as I am. You made a lot of incremental adds to various positions. I was surprised by the complete exit from OTEX at 4%. I believe you said on a number of times that one should not sell a good company unless there has been a fundamental change in the company, management or outlook. I do not see any fundamental change with OTEX. You said the stock has been a laggard. One always has some laggards in a portfolio. A steady eddy name can actually help you in these markets. Removing a 4% position seems out of sync with your style.
Thanks again.

P.S. Peter, great session with TD yesterday, even though I am not really a small cap guy.
Read Answer Asked by Dave on April 01, 2022
Q: I don't know anything about technical analysis. However, looking at the chart of XBC over the past week there appear to be clear levels of support and resistance at 1.80, 1.95 and then at 2.25, Presumably this relates to investors either taking profits or exiting at a reduced loss following the recent uptick. My question: does this chart tell us anything about future levels of support or what we might expect moving forward? Thank-you for your insight.
Read Answer Asked by Stephen on April 01, 2022
Q: AKT.A has been showing better momentum lately, but I'm still way way down on this stock. Would you continue to hold or sell and use the funds to average down on Xebec?
My other 2 options are to either sell Knight Therapeutics, or use up some of my cash to top up Xebec.
I sold both TBRD and UNS near their lows only to watch them Rocket later, so this makes me hesitant on selling my losers, i often get it wrong.
Thanks
Read Answer Asked by Gordon on April 01, 2022
Q: GSY: I've been thinking about buying this stock; however, concerned about the BOC aggressive stated policy to increase interest rates quite quickly. This and the recent report from RBC on housing service index that is high and getting higher - higher % income required to service mortgage debt. Concerned about a recession; especially, if I own this stock which probably would get killed, I would think? Comments please.
Read Answer Asked by James on April 01, 2022